OpenExamsFREE PRACTICE — ANY EXAM

Free Multistate Pharmacy Jurisprudence Examination Practice Questions

172 free questions · Answer explanations · No signup required

View examination details, outline and sources

Loading selected examination banks…

Sample Practice Questions

Try these 10 sample questions from the Multistate Pharmacy Jurisprudence Examination practice bank. Each includes the answer and explanation. Continue with the interactive practice above to review the full question set.

  1. 1A pharmacist receives an initial New Mexico pharmacist license. What is the minimum period for which that initial license must remain valid?

    1. A. At least 24 months
    2. B. At least 12 months
    3. C. At least 18 months
    4. D. At least 36 months

    Answer: A

    Explanation: Section 16.19.4.7(N) says the license is "valid for no less than 24 months," so 24 months is the minimum.

    Reference: 16.19.4 — § 16.19.4.7(N) NMAC

  2. 2A New Mexico pharmacist clinician wants to prescribe under delegated authority. What instrument defines that delegated authority?

    1. A. A pharmacy permit
    2. B. A collaborative purchase order
    3. C. A written guideline or protocol with a physician
    4. D. A technician training record

    Answer: C

    Explanation: New Mexico defines guidelines or protocol as "a written agreement between a pharmacist clinician or group of pharmacist clinicians and a physician or group of physicians that delegates prescriptive authority."

    Reference: 16.19.4 — § 16.19.4.7(M) NMAC

  3. 3When must a New Mexico pharmacist perform the prospective drug-regimen review?

    1. A. After the patient requests counseling
    2. B. After payment but before pickup
    3. C. Before dispensing any prescription
    4. D. Only when a controlled substance is prescribed

    Answer: C

    Explanation: The rule directs, "Prior to dispensing any prescription, a pharmacist shall review the patient profile."

    Reference: 16.19.4 — § 16.19.4.16(D)(1) NMAC

  4. 4A pharmacist acquires prescription stock from a supplier that is not licensed. How is that conduct treated under New Mexico rules?

    1. A. Permitted if the price is documented
    2. B. Permitted for a one-time emergency
    3. C. A recordkeeping deficiency only
    4. D. Unprofessional or dishonorable conduct

    Answer: D

    Explanation: The conduct rule includes "acquiring prescription stock from unlicensed sources" as dishonorable conduct.

    Reference: 16.19.27 — § 16.19.27.7(A)(6) NMAC

  5. 5For a New Mexico pharmacist, what period is used to determine whether continuing education was completed for renewal?

    1. A. The 12 months ending December 31
    2. B. The 24 months between the applicable birth-month endpoints
    3. C. The 18 months after initial licensure
    4. D. The 36 months preceding application

    Answer: B

    Explanation: The rule defines the renewal period as the "24 month time period occurring between the last day of the pharmacist's birth month and the last day of his/her birth month 2 years later."

    Reference: 16.19.4 — § 16.19.4.7(AA) NMAC

  6. 6What life-support credential must a New Mexico pharmacist maintain while exercising vaccine prescriptive authority?

    1. A. Current live BLS/CPR certification
    2. B. Current ACLS certification only
    3. C. Annual first-aid certification
    4. D. Pediatric advanced life support only

    Answer: A

    Explanation: The pharmacist must "complete and have current live BLS/CPR certification."

    Reference: 16.19.26 — § 16.19.26.9(B)(4) NMAC

  7. 7During prospective review, a pharmacist sees two drugs providing the same therapeutic effect without justification. Which required screening category applies?

    1. A. Incorrect duration
    2. B. Clinical misuse
    3. C. Drug-disease contraindication
    4. D. Therapeutic duplication

    Answer: D

    Explanation: The prospective review must identify "therapeutic duplication" among the listed potential problems.

    Reference: 16.19.4 — § 16.19.4.16(D)(1)(b) NMAC

  8. 8A pharmacy gives prescribers prescription blanks already printed with the pharmacy's name to solicit business. What is the regulatory characterization?

    1. A. Acceptable price disclosure
    2. B. Dishonorable solicitation of prescription business
    3. C. Permitted therapeutic interchange
    4. D. Required patient outreach

    Answer: B

    Explanation: Dishonorable conduct includes "the solicitation of prescription business by providing prescribers with prescription blanks with the name of any licensed pharmacy or pharmacist printed thereon."

    Reference: 16.19.27 — § 16.19.27.7(A)(9) NMAC

  9. 9A pharmacist is renewing an active New Mexico license. How much continuing pharmacy education is generally required every two years?

    1. A. 20 contact hours
    2. B. 24 contact hours
    3. C. 30 contact hours
    4. D. 40 contact hours

    Answer: C

    Explanation: New Mexico requires "3.0 CEU (30 contact hours) every two years."

    Reference: 16.19.4 — § 16.19.4.10(B) NMAC

  10. 10For a vaccine prescribed under New Mexico pharmacist authority, how long must the pharmacy maintain the documented informed consent?

    1. A. One year
    2. B. Two years
    3. C. Three years
    4. D. Five years

    Answer: C

    Explanation: The rule requires that informed consent be documented and "maintained in the pharmacy for a period of at least three years."

    Reference: 16.19.26 — § 16.19.26.9(D)(2) NMAC

Topics in this practice bank

These topics describe the available practice for Multistate Pharmacy Jurisprudence Examination. Review the examination outline and its sources for scope and allocation details.

  • Area 1 — Licensure/Personnel
    • Responsibilities of the pharmacist and non-pharmacist personnel: qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for pharmacists-in-charge (or equivalent) and pharmacists; qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for non-pharmacist personnel
    • Licensures, registrations, and certifications for pharmacists or non-pharmacist personnel: qualifications, examinations, internships, maintaining pharmacist competency, and renewals of licensures, registrations, or certifications; classifications and processes of disciplinary actions; reporting to and participating in programs addressing the inability to practice with reasonable skill and safety
  • Area 2 — Pharmacist Practice
    • Requirements for issuing prescriptions/drug orders: requirements for drug uses, limitations, or restrictions; scope of authority, scope of practice, limitations or restrictions of practice, and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs; requirements for issuing non-controlled prescriptions/drug orders; requirements for issuing controlled prescriptions/drug orders; authority limitations of practitioners' ability to authorize refills
    • Conditions under which the pharmacist or non-pharmacist personnel participates in the administration of drugs in the management of patients' therapy
    • Requirements regarding counseling: counseling or offering to counsel; documenting counseling or documenting offering to counsel
    • Returning or reusing drugs
    • Regulations and agencies regarding pharmacy practice: requirements for promoting quality and safety of public health; protecting patient and health record confidentiality
  • Area 3 — Dispensing Requirements
    • Responsibilities for determining whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions
    • Transferring prescription/drug order information between pharmacies by authorized personnel
    • Prospective drug utilization reviews: requirements for reporting to PMP and accessing PMP data
    • Exceptions to dispensing or refilling prescriptions/drug orders
    • Labeling of dispensed drugs
    • Packaging of dispensed drugs
    • Drug product conditions prohibiting dispensing
    • Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs: dispensing or administration; labeling of non-prescription drugs and devices; packaging and repackaging of non-prescription drugs and behind-the-counter products; dispensing-restricted, non-prescription drugs
  • Area 4 — Pharmacy Operations
    • Ordering, acquisition, and distribution of drugs, including maintenance and content of such records: ordering and acquisition, including the maintenance and content of such records; distribution, including the maintenance and content of such records
    • Recordkeeping in compliance with legal requirements, including content, inventory, maintenance, storage, handling, and reporting: non-dispensing requirements for operations of pharmacies or practice settings; possession, storage, and handling of non-hazardous drugs; training, possession, handling, storage, and disposal of hazardous drugs; allowing non-pharmacist personnel access to drugs; requirements for conducting controlled substance inventories
    • Delivery of drugs
    • Conditions for permitted or mandated product selection
    • Compounding sterile, nonsterile, hazardous, and non-hazardous preparations
    • Centralized prescription processing or central-fill pharmacy dispensing
    • Requirements for the registration, licensure, certification, or permitting of a practice setting or business entity: requirements for registration, license, certification, or permitting of a practice setting; requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting; requirements for an inspection of a licensed, registered, certified, or permitted practice setting; classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting

How to use these free practice questions

Choose an answer, check the explanation, and review your progress by chapter. Practice questions and explanations are free to access without signing up.

These are independent study questions, not actual examination items. For examination requirements and official information, view Multistate Pharmacy Jurisprudence Examination details.